Found 1129 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
M. Beatty, Boni, M. F., Brown, S., Buathong, R., Burke, D., Coudeville, L., Cummings, D. A. T., Edelman, R., Farrar, J., Focks, D. A., M Gomes, G. M., Guignard, A., Halstead, S., Hombach, J., Knerer, G., Koelle, K., Lam, F. Chang, Lang, J., Longini, I., Medlock, J., Namgyal, P., Powell, M., Recker, M., Rohani, P., Standaert, B., Struchiner, C., Teyssou, R., and Wearing, H., Assessing the potential of a candidate dengue vaccine with mathematical modeling., PLoS neglected tropical diseases, vol. 6, no. 3, p. e1450, 2012.
P. Bebas, Goodall, C. P., Majewska, M., Neumann, A., Giebultowicz, J. M., and Chappell, P. E., Circadian clock and output genes are rhythmically expressed in extratesticular ducts and accessory organs of mice., The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 23, no. 2, pp. 523-33, 2009.
B. R. Beechler, Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus?, Transbound Emerg Dis, vol. 62, no. 1, pp. 24-32, 2015.
B. R. Beechler, Jolles, A. E., and Ezenwa, V. O., Evaluation of hematologic values in free-ranging African buffalo (Syncerus caffer)., Journal of wildlife diseases, vol. 45, no. 1, pp. 57-66, 2009.
B. R. Beechler, Enemies and turncoats: bovine tuberculosis exposes pathogenic potential of Rift Valley fever virus in a common host, African buffalo (Syncerus caffer)., Proc Biol Sci, vol. 282, no. 1805, 2015.
B. R. Beechler, Broughton, H., Bell, A., Ezenwa, V. O., and Jolles, A. E., Innate immunity in free-ranging African buffalo (Syncerus caffer): associations with parasite infection and white blood cell counts., Physiological and biochemical zoology : PBZ, vol. 85, no. 3, pp. 255-64, 2012.
B. R. Beechler, Broughton, H., Bell, A., Ezenwa, V. O., and Jolles, A. E., Innate immunity in free-ranging African buffalo (Syncerus caffer): associations with parasite infection and white blood cell counts., Physiological and biochemical zoology : PBZ, vol. 85, no. 3, pp. 255-64, 2012.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex., The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. E. Bermudez, The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report., Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 19, no. 2, pp. 159-65, 1986.
L. E. Bermudez, Petrofsky, M., and Shelton, K., Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection., Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.
L. E. Bermudez, Petrofsky, M., and Sangari, F., Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype., Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.
L. E. Bermudez and Young, L. S., Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages., Journal of immunology (Baltimore, Md. : 1950), vol. 146, no. 1, pp. 265-70, 1991.
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.
L. E. Bermudez, Kolonoski, P., and Young, L. S., Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model., Journal of leukocyte biology, vol. 47, no. 2, pp. 135-41, 1990.
L. E. Bermudez, [Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients]., Revista paulista de medicina, vol. 105, no. 6, pp. 341-6, 1987.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease., Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
L. E. Bermudez, Inderlied, C. B., and Young, L. S., Mycobacterium avium complex in AIDS., Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.
L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., Isolation of two subpopulations of Mycobacterium avium within human macrophages., FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.
L. E. Bermudez, Motamedi, N., Kolonoski, P., Chee, C., Baimukanova, G., Bildfell, R. J., Wang, G., Phan, L. Tam, and S Lowell, Y., The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection., The Journal of infectious diseases, vol. 197, no. 11, pp. 1506-10, 2008.
L. E. Bermudez, Wu, M., and Young, L. S., Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium., Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease., The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez, Young, L. S., and Gupta, S., 1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF., Cellular immunology, vol. 127, no. 2, pp. 432-41, 1990.
L. E. Bermudez, Sangari, F. J., and Parker, A., Green fluorescent protein in the measurement of bacteria-host interactions., Methods in enzymology, vol. 302, pp. 285-95, 1999.
L. E. Bermudez, Young, L. S., and Inderlied, C. B., Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells., Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.

Pages